Metabolic syndrome And Severity of Covid-19
Recruiting
- Conditions
- Covid-19 infection
- Registration Number
- NL-OMON25762
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Age > 18 years old and no treatment restrictions
Exclusion Criteria
Patient not able to stand straight, this is necessary to measure the hip-waist ratio.
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ?- BMI<br>?- Hip- waist ratio <br>?- Covid-19 laboratory test (Ferritin, triglycerides, HDL-cholesterol, CRP, procalcitonin, ALAT, ASAT, GGT, AF, glucose, LDH, sodium, potassium <br>?- CT-scan; CO-RADS and severity score<br>?- Medication use (statins, inhalation corticosteroids, antihypertension medication etc.)<br>?- Severity of covid-19 infection defined by hospitalization, oxygen suppletion and intubation and ventilation at the intensive care. <br>?- Outcome after 30 days (complete recovery, rest abnormality, deceased) <br>
- Secondary Outcome Measures
Name Time Method ?- Diameter of fat on sternum (measuring on the CT at xyphoid)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does metabolic syndrome influence cytokine storm pathways in severe Covid-19 patients?
What biomarkers predict severe Covid-19 outcomes in patients with insulin resistance and obesity?
What are the comparative outcomes of standard-of-care treatments in metabolic syndrome vs. non-metabolic syndrome Covid-19 patients?
How do ACE2 receptor dysregulation and adipokine imbalances contribute to metabolic syndrome-related Covid-19 severity?
What combination therapies targeting metabolic syndrome and SARS-CoV-2 replication show promise in clinical studies?